In a regulatory filing, EyePoint disclosed that its director Ye Liu sold 1.91M shares of common stock on January 11th in a total transaction size of $37.2M.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on EYPT:
- EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
- Insider Trading: EyePoint Stock (NASDAQ:EYPT) Up on Major Insider Buy
- EyePoint announces first patient dosed in Phase 2 VERONA trial
- EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 2 VERONA Clinical Trial of EYP-1901 for the Treatment of Diabetic Macular Edema
- Short Report: Bearish position in Carvana nudges higher as shares slip